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ABSTRACT
CHARACTERIZATION OF THE VASOACTIVITY OF TACHYKININS IN 
ISOLATED RAT KIDNEY: Functional Studies and in vitro 
Receptor Autoradiography
by
Yuejin Chen
Although tachykinins have potent vascular actions, their effect on renal 
resistance blood vessels is currently unknown.
The vasoactive properties of tachykinins and related analogs were assessed 
in isolated perfused rat kidney. At a basal perfusion pressure (PP) of 75 ± 6 mm 
Hg (n=5), bolus injections of substance P (SP) had no significant vasoactive 
effect. Following a sustained increase in baseline PP (134 ± 10 mm Hg) 
produced by phenylephrine (1 /tM), SP evoked a dose-dependent increase in PP. 
The largest dose of SP increased PP by 60 ± 5 mm Hg. The vasoconstrictor 
response to SP was not blocked by phentolamine when angiotensin II was used to 
increase basal tone. Thus, the response to SP is not mediated by norepinephrine. 
Pressor responses to SP were not potentiated by peptidase inhibitors, captopril 
and thiorphan. SP(l-7) had no effect on PP, suggesting that the pressor response 
to SP is C-terminal dependent and tachykinin receptor mediated. The selective 
NK-1 receptor agonist, [Sar9,M et(02)n]SP, had no effect on PP. In contrast, both 
the selective NK-2 and NK-3 receptor agonists, GR-64349 and [MePhe7]NKB, 
produced dose-dependent pressor responses (116 ± 8 and 134 ± 15 mm Hg 
increases in PP at 33 nmol, respectively) and were more potent than SP. Infusion 
of capsaicin (500 nM) produced an initial increase in PP following by a more 
prolonged decrease in PP. Clamping the renal vein produced a marked increase 
in PP.
The localization of NK-3 receptors in rat kidney evaluated by film 
autoradiography using 125I-[MePhe7]NKB revealed a high density of specific 
binding sites on the proximal ureter and renal pelvis, moderate density in the 
renal vein and its large branches, and a low density in the inner strip of outer 
medulla, but no specific binding on the renal artery system and cortex. High 
resolution autoradiograms demonstrated 125I-[MePhe ]NKB binding sites on the 
tunica media of the renal vein and tunica muscularises of renal pelvis and ureter. 
Specific binding of 125I-BHSP was found in association with the renal artery and 
renal pelvis. No specific SP binding sites were associated with renal vein.
These data indicate that the pressor effect of tachykinins in the isolated rat 
kidney can be mediated by NK-2 and/or NK-3 receptors. The latter may be on 
the vascular smooth muscle of the renal vein.
iii
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CHAPTER 1 
Introduction
The Problem
Statement of the Problem
The tachykinins, substance P (SP), neurokinin A (NKA) and neurokinin B 
(NKB) belong to a family of peptides with similar biological actions and a 
common amino acid sequence at the C-terminus (Helke et al., 1990).
Immunocytochemical study has demonstrated that SP and NKA are found in a 
subpopulation of primary sensory nerves that have a widespread distribution in 
the cardiovascular system (Wharton and Gulbenkian, 1989). Recently, 
considerable evidence has mounted supporting the concept that tachykinin- 
containing sensory neurons participate in regulation of vascular functions in many 
somatic and visceral tissues through their duel afferent and efferent actions. In 
addition to their potential role in the reflex control of the circulation via the 
actions at central release sites, tachykinins released from peripheral sensory nerve 
terminals also may exert an important local control over vascular effector 
functions (Maggi, 1991; Holzer, 1992). Pharmacological studies have revealed 
that the efferent functions of tachykinins on the vasculature are variable among 
different species and blood vessel studied and are dependent on different 
tachykinin receptors. Vasoconstrictor effects can occur through stimulation of any 
class of tachykinin receptors on vascular smooth muscle cells, while vasodilation
1
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may result from stimulation of NK-1 receptors on thevascular endothelium and is 
mediated by endothelium-derived relaxing factor (Stewart-lee and Burnstock,
1989; Whittle et al, 1989). Until recently, however, most studies on the vascular 
pharmacology of tachykinins have been performed on large vessels.
It is well established that the rat kidney is innervated by both sensory and 
postganglionic autonomic nerves (Barajas et al, 1992). While much was known 
about the renal efferent sympathetic innervation, little was known about the renal 
afferent innervation until recently. Anatomical studies of rat kidney have 
identified SP-immunoreactive nerves that innervate the renal artery and its 
branches, and the renal veins (Ferguson and Bell, 1985; Knight et al, 1987). 
Likewise, the presence of NKA and NKB in the rat kidney was also suggested 
based on the results of radioimmunoassays with reportedly selective antibodies 
(Tateishi et al, 1990). Data from functional studies have shown that SP can 
increase the basal tone of rat renal conduit vessels (Bredy-Dobreva et al, 1988), 
relax rabbit renal arterial segments contracted by exposure to norepinephrine or 
phenylephrine (Malomvolgyi et al, 1988), and increase total renal blood flow in 
the dog (Defelice and Brousseau, 1988). However, the effect of tachykinins on 
renal resistance vessels has received comparatively little attention. Moreover, no 
systematic studies have been performed to identify the classes of tachykinin 
receptors that mediate the responses of the renal vasculature to these peptides.
Thus, the present study was designed to characterize vasoactivity of 
tachykinins in isolated perfused rat kidney by using functional studies and in vitro
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3receptor autoradiography.
Significance of the Problem
Basic science advancements provide a foundation for the recognition of the 
physiological and pathophysiological significance of the tachykinins in various 
systems and possibly in various types of human diseases. Evidence supporting the 
involvement of SP in the pathology of a variety of diseases has been derived from 
studies of animal models and humans (Payan, 1989; Holzer, 1992). It is believed 
that SP or other tachykinins released from nerve endings by various stimuli can 
elicit diverse biological activities including smooth muscle contraction, 
vasoconstriction or/and vasodilation, plasma extravasation and protein secretion 
from distinct glands, all of which are referred to as local neurogenic inflammation 
(Payan, 1989). It was suggested that the release of SP in pulmonary tissues under 
certain circumstances may be involved in the pathogenesis of bronchial asthma 
(Frossard and Advenier, 1991). In a rat model of arthritis, it was found that joints 
that developed more severe arthritis were more densely innervated by SP- 
containing neurons than joints that developed less severe arthritis (Levine et al., 
1984). In addition, in colon tissue obtained from patients with chronic 
inflammatory bowel diseases, SP binding sites are present in higher than normal 
concentrations (1,000-2,000 times normal) in arterioles, venules, and lymph 
nodules in the inflamed tissue (Mantyh et al., 1988). Therefore, quite similar 
considerations regarding the pathophysiological role of tachykinins in diseases of 
the renal vasculature or kidney could be made and remain to be examined. The
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
present study will provide a basis for understanding the potential role of 
tachykinins in the local control of the renal circulation and is an essential 
prerequisite for the subsequent evaluation of possible tachykinin involvement in 
the pathogenesis of diseases affecting the renal vascular bed and/or kidney such 
as nephritis and some types of hypertension.
Hypothesis
Based on previous work by other investigators as well as our preliminary 
experiments that have demonstrated that SP has a pressor effect in the isolated 
perfused rat kidney, the hypothesis to be tested in this study is that the pressor 
effect of tachykinins in isolated rat kidney is mediated by tachykinin receptors on 
the renal resistance vessels.
If tachykinin receptors are present in any segment of renal resistance vessels, 
then exogenous and/or endogenous tachykinins and their agonists should have 
vasoactive effects indicated by changes in perfusion pressure under appropriate 
experimental conditions. As mentioned above, it is anticipated that these 
responses would be dependent upon receptor type, vessel segment and species. 
Functional experiments using selective tachykinin agonists could demonstrate 
which type of tachykinin receptor is present in renal vasculature but could not 
identify the regional or cellular localization of these tachykinin receptors. 
However, if tachykinin receptors are present in the renal vasculature, and a 
vasoactive effects of tachykinin agonists could be proved by functional studies, it 
should be possible to determine their localization by receptor autoradiography
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
using selective radioligands. It is possible that any class of tachykinin receptor is 
present in vascular smooth muscle, but only NK-1 receptors would be expected to 
occur on vascular endothelium.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER 2 
Review of Literature
The Efferent Function of Sensory Nerves 
It is now recognized that in addition to the classical adrenergic and cholinergic 
innervation, the cardiovascular system is also widely supplied by non-adrenergic, 
non-cholinergic (NANC) nerves, some of which utilize peptides such as SP and 
calcitonin gene-related peptide (CGRP) as their transmitters (Holzer, 1992).
These perivascular NANC nerves are in fact primary sensory nerve fibers that are 
able to monitor the changes in their chemical and physical environment, convey 
this information to the central nervous system, and initiate autonomic homeostatic 
reflexes. In addition to their sensory roles, the peptidergic afferent neurons also 
have a distinct feature -- local effector functions via the release of neuropeptides 
from their peripheral terminals (Holzer, 1988; Maggi, 1991). As shown in Fig. 1, 
the sensory nerve fibers bifurcate in the periphery, one branch forming the 
sensory ending for reception of the irritant stimulus and the other supplying a 
blood vessel. When the sensory ending is activated, nerve impulses travel not only 
centrally but also pass antidromically to the blood vessel to cause vasodilation. 
Moreover, the neurotransmitters also may be released from the same terminal 
activated by the environmental stimulus (Maggi and Meli, 1988). This efferent 
function of sensory afferents provides a basis for speculating on a possible role of 
these nerves in regulating vascular tone.
Although the significance and mode of action of afferent neurons in the
6
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Figure. 1. Peptidergic Sensory Neurons in the Control of Vascular Function
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control of vascular functions is only now being appreciated, the demonstration 
that certain sensory nerves release transmitters from their peripheral endings can 
be traced back to classic works of Strieker (1876) and Bayliss (1901) (see review 
by Maggi, 1991). Bayliss showed that the vasodilation produced by electrical 
stimulation of dorsal roots was unaffected by removal of the dorsal root ganglia 
and consequent degeneration of afferent nerves abolished it. On this basis,
Bayliss concluded that the observed vasodilatation was produced by impulses 
conveyed along afferent fibers in an efferent direction (Maggi, 1991).
A major advance contributing to the elucidation of efferent functions of 
sensory neurons came with the discovery of the pharmacological properties of 
capsaicin by a Hungarian group headed by Jancso (Jancso et al., 1968). Capsaicin 
(8-methyl-N-vanillyl-6-nonenaminde) is a pungent chemical found in a wide 
variety of red peppers (Holzer, 1991). At doses very much higher than those used 
for spicing food, this compound has been found to act as a quite selective 
neurotoxin for primary afferent neurons. Low doses of capsaicin (i.e., the 
microgram per kilogram range) induce transient excitation of thin primary 
afferent neurons while systemic administration of high doses of drug (i.e., the 
milligram per kilogram range) causes long-lasting damage to these neurons 
(Holzer, 1991). Therefore, this compound has become an important probe for 
sensory neuron mechanisms.
Studies using immunocytochemistry and radioimmunoassay have revealed the 
presence of a variety of peptides, such as tachykinins, CGRP, and vasoactive
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
9intestinal'polypeptide (VIP) in primary afferent neurons (Holzer, 1988). They are 
released from the peripheral endings of afferent neurons by depolarizing 
stimulation and act on the receptors on the target cells to produce several 
biological actions that include vasodilation and constriction, increase in venular 
permeability (plasma protein extravasation), changes in non-vascular smooth 
muscle contractility, degranulation of mast cells and a variety of effects on 
leucocytes and fibroblasts. All these effects contribute to the neurogenic 
inflammation that occurs in response to tissue injury or exposure to irritants 
(Maggi and Meli, 1988; Holzer, 1988).
Mammalian Tachykinins 
Tachykinins are closely related peptides characterized by sharing the common 
C-terminal sequence Phe-x-Gly-Leu-Met-NH, and exhibiting a similar spectrum of 
biological activities, such as exciting neurons and contracting visceral smooth 
muscles and certain blood vessels (Helke, et al., 1990; Regoli and Nantel, 1991a). 
The primary structures of several tachykinins are listed in Table 1. SP is a 
representive peptide of this family, that was first described to be present in 
extracts of horse brain and intestine by Von Euler and Gaddum in 1931 (Pernow, 
1983). The chemical structure of this peptide was not reported until four decades 
later (Pernow, 1983). The other two major tachykinins belonging to this family 
are neurokinin A (NKA, formerly called substance K) and neurokinin B (NKB, 
formerly called neuromedin K) which were isolated by Kimura et al. (1983) from 
extracts of porcine spinal cord. Also presented in Table 1. are structures of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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TABLE 1.
Primary Structure of Tachykinins and Their Agonists
Mammalian Tachvkinins 
Substance P 
Neurokinin A 
Neurokinin B
Nonmammalian Tachvkinins
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2
His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH,
Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH,
Physalaemin
Kassinin
Eledoisin
Synthetic Agonists
[Sar9,Met(02)n]SP
GR-64349
[MePhe7]NKB
Senktide
pGlu-Ala-Asp-Pro-Asn-Lys-Phe-Tyr-Gly-Leu-Met-NH,
Asp-Val-Pro-Lys-Ser-Asp-Gln-Phe-Val-Gly-Leu-Met-NH,
pGlu-Pro-Ser-Lys-Asp-Ala-Phe-Ile-Gly-Leu-Met-NH,
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met(0,) NH, 
H2N-(CH2)4-CO-Phe-Phe-Pro-NMeLeu-Met-NH2 
Asp-Met-His-Asp-Phe-Phe-MePhe-Gly-Leu-Met-NH, 
succinyl-Asp-Phe-MePhe-Gly-Leu-Met-NH,
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physalaemin (Phy), eledoisin (Ele) and kassinin (Kas). These tachykinins are 
present in amphibians but not in mammals (Helke et al, 1990; Regoli et al,
1991b). However, they have been widely used in the pharmacological evaluation 
of tachykinin receptors.
Mammalian tachykinins are the products of two distinct genes (Helke et al, 
1990). SP and NKA are derived from the preprotachykinin (PPT) gene-A. 
Alternative RNA splicing of the primary transcript gives rise to three different 
mRNAs encoding distinct tachykinin precursor proteins: a-PPT-A, which codes 
only for SP and B-PPT-A and y-PPT-A which code for both SP and NKA. NKB 
mRNA is synthesized from a separated gene, the preprotachykinin gene-B. 
Variable splicing of the primary transcript yields two different mRNAs, both of 
which code only for NKB. However, PPT-A and PPT-B genes exhibit a marked 
structural similarity, suggesting that they evolved from a common ancestor gene by 
duplication events (Ohkubo and Nakanishi, 1991). The preprotachykinin mRNAs 
and peptide products are differentially distributed throughout the nervous system 
and periphery (Helke et al, 1990). NKA coexists with SP in primary sensory 
neurons (Dalsgaard et al, 1985; Couture and Kerouac, 1987; Tateishi et al, 1990).
Tachykinin Receptors and Agonists 
It is clear that the presence or absence of postsynaptic receptors is critical in 
determining the response to released transmitter. Pharmacological, biochemical 
and histochemical studies have lead to the proposal that there are at least three 
distinct tachykinin receptors, namely NK-1, NK-2 and NK-3. SP, NKA and NKB
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are the natural agonists for these receptors. SP has the highest affinity among the 
natural peptides for the NK-1 receptor, while NKA and NKB have highest 
affinities for NK-2 and NK-3 receptors, respectively. However, none of these 
endogenous tachykinins are highly selective for a given receptor and all can act on 
each of the tachykinin receptors at high enough concentration (Regoli and Nantel, 
1991a). Fortunately, there are synthetic tachykinin analogues (see Table. 1) that 
display considerable receptor selectivity. For instance, [Sar9,M et(02)n]-SP is a 
selective NK-1 receptor agonist with negligible activity at NK-2 and NK-3 
receptors (Regoli et al, 1988), GR-64349 (Hagan et al., 1991) is a selective NK-2 
receptor agonist, while succinyl-[Asp6,MePhe8]-SP6.n (Senktide) and [MePhe7]- 
NKB (Regoli et al., 1988) are selective NK-3 receptor agonists. The proposed 
presence of an additional type of tachykinin receptor, such as the NK-4 (Mcknight 
et al, 1988; Burcher et al., 1991) and further tachykinin receptor subtypes such as 
NK-1A, NK-1B remain to be proven (Burcher et al, 1991).
The molecular identification of three tachykinin receptors from rat, mouse, 
guinea pig, bovine and human has been recently accomplished by cDNA cloning. 
Rat NK-1, NK-2 and NK-3 receptors consist of 407, 390 and 453 amino acid 
residues, respectively (Gerard et al, 1993). The overall homology of these 
receptors within a single species (rat) is approximately 60% and their core 
sequences are highly conserved. The overall homology of each type of receptor 
among species is greater than 85-90% (Nakanishi, 1991; Burbach and Meijer, 
1992; Ohkubo and Nakanishi, 1991). All tachykinin receptors have seven
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hydrophobic domains with extracellular amino termini and cytoplasmic carboxyl 
termini and share a significant sequence similarity with other G-protein coupled 
receptors. Thus, all three receptors belong to the family of G-protein coupled 
receptors (Nakanishi, 1991; Krause et al, 1993). It was observed that stimulation 
of tachykinin receptors caused activation of phospholipase C, catalyzing the 
hydrolysis of phosphoinositides into inositol 1,4,5-trisphosphate and diacylglycerol. 
These second messengers are then available for the mobilization of calcium from 
internal reticular stores via the inositol 1,4,5-trisphosphate receptor and for the 
activation of protein kinase C (Ohkubo and Nakanishi, 1991; Guard et al., 1988; 
Guillemain et al, 1992; Gerard et al., 1993). In some preparations, tachykinins 
also enhanced synthesis of cyclic AMP (Narumi and Maki, 1978; Yamashita et al, 
1983). Therefore, tachykinin receptors are thought to act through multiple G- 
proteins to activate phosphatidylinositol-Ca++ and/or cAMP system (Gerard et al., 
1993).
The distribution of tachykinin receptors in the central nervous system and 
peripheral tissues has been studied extensively by biochemical and 
autoradiographic analysis of tachykinin binding sites (Mantyh et al, 1989; Otasuka 
and Yoshioka, 1993). The distribution of the three tachykinin receptor mRNAs in 
various tissues of the rat has also been investigated by RNA blot hybridization 
using each of the three receptor cDNAs (Ohkubo and Nakanishi, 1991). It was 
found that the NK-1 receptor is widely distributed both in the central nervous 
system and in peripheral tissues. The NK-3 receptor is also distributed in various
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tissues, but it is expressed more in the central nervous system than in peripheral 
tissues. In contrast, NK-2 receptor is predominantly expressed in peripheral 
tissues (Mantyh et al, 1989; Ohkubo and Nakanishi, 1991; Otasuka and Yoshioka, 
1993). Thus, the three receptors and their mRNAs are expressed differently in 
the central nervous system and peripheral tissues.
Effects of Tachvkinins on the Vasculature 
Immunocytochemical evidence has demonstrated that SP-containing primary 
sensory nerve fibers are widely distributed in the cardiovascular system in a 
variety of mammals, including humans (Wharton and Gulbenkian, 1989). These 
immunoreactive nerve fibers are generally sensitive to capsaicin and have been 
identified in heart, around both large conducting arteries and veins, and in small 
vessels supplying many vascular beds (Barja and Mathison, 1982; Furness et al, 
1982; Brodin and Nilsson, 1981). In addition to SP, these nerves contain NKA 
and CGRP (Wharton and Gulbenkian, 1989).
It has been shown that SP and CGRP are released from both the arterial and 
venous mesenteric vasculature by capsaicin and antidromic nerve stimulation, and 
a significant reduction in the quantity of these peptides was observed in the same 
tissue from capsaicin-pretreated animals (Manzini et al., 1991). Stimulation of 
sensory nerve endings in cerebral vessels is also associated with a release of SP 
(Holzer, 1988). These observations suggest that the local release of sensory 
neuropeptides from capsaicin-sensitive nerve endings might be important for the 
regulation of vessel tone.
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On the other hand, SP binding sites have been identified by in vitro 
autoradiographic mapping in endothelium of blood vessels from guinea pig and 
human lung and from dog carotid artery (Wharton and Gulbenkian, 1989; 
Stephenson et al., 1986). The presence of NK-2 receptors in rat portal vein has 
also been suggested based on work with selective agonists (Chassaing et al, 1991).
The pharmacological effects of tachykinins on the vasculature have been 
evaluated extensively. It was found that SP had a vasodilator effect through NK-1 
receptors on the endothelium of dog isolated carotid artery and guinea pig 
coronary vessels preconstricted with NE and vasopressin, respectively (Regoli, et 
a/., 1988; Hoover and Hossler, 1993). In contract, SP elicited a vasoconstrictor 
response mediated by the same receptor located on smooth muscle in the rabbit 
jugular and mesenteric veins (Regoli et al., 1984; Nantel et al., 1990). In rabbit 
pulmonary artery, SP and NKA evoke relaxation through NK-1 receptors on 
endothelium and contractions by stimulating NK-2 receptors on the vascular 
smooth muscle (Regoli et al., 1984). It has been reported that NKB and NKA 
contract the rat portal vein by activating a large population of NK-3 receptors and 
a minor population of NK-2 receptors presumably located on the smooth muscle 
(Mastrangelo et al., 1986; Chassaing et al., 1991). In a recent study, Orleans-Juste 
et al. (1991) reported that the arterial and venous mesenteric vascular bed of the 
rat are insensitive to SP, yet the venous side had a constrictor response to NKB 
and was even more sensitive to [MePhe7]-NKB, a selective NK-3 agonist. The
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latter findings suggest that tachykinin receptors in the mesenteric vasculature of 
rats are restricted to the venous side and are solely the NK-3 type. Therefore, 
tachykinins may stimulate or inhibit a variety of vascular smooth muscles by direct 
or indirect mechanisms and may thereby affect peripheral blood flow. The 
vascular response to tachykinins can vary between blood vessels and species.
While vasoconstrictor effects can occur through stimulation of any class of 
tachykinin receptors on vascular smooth muscle cells, vasodilation has only been 
observed after stimulation of NK-1 receptors on the vascular endothelium and is 
mediated by endothelium-derived relaxing factor (Stewart-lee and Burnstock,
1989; Whittle et al., 1989). Moreover, all three tachykinins can increase vascular 
permeability and induce plasma protein extravasation (Gamse and Saria, 1985; 
Couture and Kerouac, 1987; Jacques et al., 1989).
Termination of Tachykinin Actions 
Since reuptake into nerve terminals does not occur with neuropeptides, 
diffusion and degradation by peptidase are the main mechanisms by which their 
action is terminated (Couture and Kerouac, 1987; Holzer, 1992). Biochemical 
studies have shown that several peptidases such as neutral endopeptidase 24.11 
(NEP) and angiotensin converting enzyme (ACE) are potentially involved in the 
degradation of tachykinins in both the central nervous system and periphery 
(Turner, 1987; Frossard et al., 1989). NEP is a membrane-bound enzyme present 
in a variety of tissues including the vascular system. It has been demonstrated 
that the actions of SP and NKA on the guinea pig isolated urinary bladder and
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ferret trachea and that of SP on rat portal vein were significantly potentiated by 
thiorphan, an endopeptidase 24.11 inhibitor (Rouissi et al., 1990; Maggi et al, 
1990). However, NEP is not active in all systems. For example, relaxation of rat 
gastric fundus induced by SP was not influenced by two endopeptidase inhibitors, 
thiorphan and phosphoramidon (Smits and Lefebvre, 1991). In addition, it was 
found that captopril, an ACE inhibitor, significantly potentiated the maximal 
response of dog carotid artery and rabbit pulmonary artery to SP, NKA and NKB, 
and of rat portal vein to SP (Rouissi et al, 1990), suggesting ACE can play a 
significant role in terminating the action of tachykinins in some tissues. On the 
other hand, responses to NKA and NKB were not affected by ACE inhibition in 
rat portal vein and lung (Hooper and Turner, 1986; Rouissi et al., 1990). These 
results indicate that tissue and species differences are important factors in regard 
to tachykinin degradation by peptidases.
Tachvkinins in the Kidney and Renal Vasculature 
Neural regulation of the renal circulation is important in adjusting vessel tone 
that determines the distribution of blood flow within the organ and ultimately 
regulates blood pressure. While much is known about the renal efferent 
sympathetic innervation, little is known about the renal afferent innervation until 
recently. The intrarenal localization of sensory nerves has been investigated with 
the help of immunocytochemical methods for SP and CGRP which are generally 
regarded as markers for afferent fibers. Accumulated evidence supports the view 
that SP and CGRP coexist in a subpopulation of sensory nerve fibers that supply
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
18
the renal vasculature. By using a highly specific anterograde nerve tracing 
technique with wheat germ agglutinin-horseradish peroxidase, Marfurt and 
Echtenkamp (1991) found that labeled afferent fibers were seen around branches 
of the renal artery, interlobar arteries and arcuate arteries, and sparsely 
innervated the renal vein. Anatomical studies of the rat kidney have identified 
SP-immunoreactive nerves that innervate the arcuate arteries, interlobular arteries 
and afferent arterioles (Knight et al., 1987), and the wall of the renal artery and 
vein where they enter the renal hilus (Ferguson and Bell, 1985), suggesting that 
SP might affect the renal vasculature at several sites. Although there has been no 
report about the presence of NKB or NKA in SP/CGRP containing sensory nerve 
innervation in renal vasculature, biochemical experiments using selective 
antibodies have detected the presence of NKA- and NKB-like immunoreactivities 
in extracts of rat kidney (Tateishi et al., 1990). Furthermore, Tsudhida et al.
(1990) reported the presence of mRNA for NK-3 receptors in rat kidney based on 
blot-hybridization and RNase-protection analyses using tachykinin receptor 
cDNAs.
In pharmacological studies, previous investigators have reported that SP 
can increase the basal tone of rat renal artery and cause relaxation of rabbit renal 
arterial segments contracted by exposure to norepinephrine, elevated potassium 
levels, prostaglandin or phenylephrine (Bredy-Dobreva et al., 1988; 
Malomvolgyi et al., 1988). Infusion of SP into the renal artery of anesthetized 
dogs causes a dose-dependent increase in total renal blood flow, indicating that
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
the peptide has a relaxant effect on renal resistance vessels in this species 
(Defelice and Brousseau, 1988). Moreover, specific SP binding sites with NK-1 
receptor characteristics were subsequently identified in several blood vessels of 
the dog kidney, including the afferent arterioles (Stephenson et al., 1987). The 
effect of tachykinins on renal resistance vessels had not been evaluated in other 
species.
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CHAPTER 3 
Materials and Methods
Functional Studies
Isolated Perfused Rat Kidnev Preparation
Male Sprague-Dawley rats (350-450 g) from our breeding colony were used. 
Viral antigen-free breeders were purchased from Charles River Laboratories 
(Raleigh, NC). Animals were deeply anesthetized with sodium pentobarbital (70 
mg/kg, i.p.). The abdomen was opened by a midline incision. The aorta was 
ligated above and below the left renal artery after the surrounding connective 
tissue was carefully removed in situ. With the aid of a stereomicroscope, a small 
polyethylene tube (PE 20) was inserted into the renal artery as described by 
Schwartz and Malik (1989) and flushed with 1 ml heparinized saline (200 
units/ml). The kidney was removed, placed in a perfusion apparatus (Fig. 2) and 
perfused with a modified Krebs-Ringer bicarbonate buffer containing (millimolar): 
NaCl, 127.2; KC1, 4.7; CaCl2, 2.5; KH2P 04, 1.2; NaHC03, 24.9; MgS04, 1.2; 
sodium pyruvate, 2.0; dextrose, 5.5 and 0.1% bovine serum albumin (BSA). The 
perfusion fluid was prewarmed and maintained at 37° C and continuously gassed 
with a mixture of 95% 0 2 and 5% C 0 2. Kidneys were perfused at a constant 
flow rate of 3 m l/min/g of contralateral kidney using a Masterflex peristaltic 
pump (Cole Parmer, St. Louis, MO). The renal perfusate was allowed to flow 
through the cut ends of the renal vein and ureter and not recirculated. Perfusion
20
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
21
buffer
\
100pl 
bolus injections
p ressu re
transducermm Hg
■ Venous 
e f f lu e n t
Figure 2. Isolated Perfused Kidney Preparation
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pressure (PP) was measured with a Statham-Gould P23ID pressure transducer 
(Gould, Cleveland, OH) attached to a three-way stopcock at the end of the renal 
artery cannula to monitor changes in vascular tone with a Gould 2400S recorder 
(Gould, Cleveland, OH). SP and other tachykinins were dissolved in 0.1% 
BSA/saline or other diluent and administered by bolus injection of 100 fi\ into the 
perfusing solution via an injection port close to the three-way stopcock (Fig. 2).
In all experiments, the PP was allowed to return to baseline before the 
administration of a subsequent dose of agonist to avoid desensitization. The 
minimum time between injections was 5 min. All injections caused a small 
injection artifact in the PP record. Vehicle injection did not have a significant 
effect on PP. Each dose-response curve was constructed using data obtained from 
4-9 kidneys.
Measurements of Pressor Responses to SP. NE and Tvramine at Basal and 
Elevated Perfusion Pressure
Kidneys were perfused with normal buffer for a 30 min equilibration period. 
Four doses of SP were given in order of ascending concentration (i.e., 1, 3, 10 and 
33.3 nmol) and responses recorded. Then, the perfusion was switched to buffer 
containing 1 n M phenylephrine (PHE), a selective a,-adrenergic agonist, to 
increase vascular tone. After another 30 min period for stabilization at a higher 
PP, a second set of SP dose-response data was obtained. Similar experiments 
were done with NE and tyramine except for using only one dose of each (100 
pmol and 10 jitmol, respectively).
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Effect of Phentolamine on Pressor Responses to SP and NE
The effect of phentolamine, an a-adrenergic antagonist, on the responses to 
SP and NE was evaluated in paired experiments in the presence of 0.22-0.25 /iM 
angiotensin II (All) to elevate vascular tone. Kidneys were perfused with normal 
buffer for 30 min, then All was infused into the perfusion buffer at a site near the 
renal artery cannula by a Harvard syringe infusion pump (Harvard Apparatus, 
South Natick, MA). The infusion was started 15 min before beginning bolus 
injections of SP (33.3 nmol) and NE (333 pmol). After recovery from control 
responses to SP and NE, the All infusion was stopped and perfusion was switched 
to buffer containing 1 phentolamine. After a 20 min equilibration period, the 
same protocol of All infusion and bolus drug injections was repeated.
Effects of Thiorphan. Captopril and Indomethacin on Pressor Response to SP 
After a 30 min perfusion of the isolated rat kidney with normal buffer, 
perfusion was switched to buffer containing 1 //M PHE plus either 10 /tM 
thiorphan (endopeptidase inhibitor), 10 /rM captopril (ACE inhibitor), or 5 /tM 
indomethacin (cyclooxygenase inhibitor). Dose-response effects of SP on PP were 
assessed beginning at least 30 min after switching to the treatment buffer. Results 
were compared to those obtained in the presence of PHE alone.
Effects of Natural and Receptor Selective Tachvkinins on Perfusion Pressure 
Since preliminary experiments demonstrated that increased vascular tone was 
required for SP to elicit pressor responses, the vascular effects of all other
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tachykinins were evaluated after increasing baseline perfusion pressure using 1 
fiM. PHE. The perfusion was switched to buffer containing PHE after 30 min of 
perfusion with normal buffer. Injections of tachykinins and vehicle were started 
after another 30 min stabilization period and given in order of ascending dose 
(i.e., 1, 3.3, 10, 33.3 nmol).
Effect of in vitro Capsaicin Treatment
The kidney was initially perfused for 30 min with normal buffer. After 
another 30 min perfusion with 1 fiM  PHE buffer, the perfusion was switched to 
buffer also containing 0.01% ethanol (vehicle for capsaicin) for 20 min as control. 
This was followed by a 15 min perfusion using PHE buffer without ethanol. Then 
the kidney was perfused for 20 min with buffer containing capsaicin (500 nM, 
containing 0.01% ethanol).
Partial Occlusion and Clamping of the Renal Vein
The proximal renal vein was isolated from surrounding connective tissue prior 
to removal and perfusion of the left kidney as described previously. Kidneys were 
perfused with normal buffer and 1 PHE buffer each for 30 min. During 
continued perfusion with PHE buffer, a polyethylene cannulae (PE 60, external 
diameter 1.6 mm, internal diameter 1 mm) was inserted retrogradely into the 
renal vein (diameter about 2 mm) for a short of period time to determine the 
effect of partial venous occlusion on arterial PP. After removing the cannula and 
allowing PP to return to the baseline value, the renal vein was clamped for
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several seconds by a hemostat to determine the effect of total venous occlusion on 
PP.
In vitro Receptor Autoradiography
Animal and Tissue Preparation
Male Sprague-Dawley rats (350-450 g body weight) were deeply anesthetized 
with sodium pentobarbital (65 mg/kg, i.p.), and the kidneys were exposed 
through a midline abdominal incision. The kidneys and, in some experiments, the 
proximal part of the renal artery, renal vein and ureter were removed and 
carefully cleaned of surrounding fatty tissue prior to placement on brass 
microtome specimen plates and freezing with dry ice. Parasagittal, 20 ^m-thick 
sections of kidney were cut on a microtome cryostat at - 20° C and thaw mounted 
onto chrome alum/gelatin-coated microscope slides. Groups of three consecutive 
sections were collected serially. The first section of each group was stained with 
hematoxylin and eosin for identification of tissue structures. The remaining 
sections were used for autoradiography. The brain was also removed and 
sectioned as described for study as a positive control. The slides were transferred 
to plastic slide boxes on dry ice as soon as the tissue was dried and stored at -70° 
C until used.
Receptor Labelling
12SI-(MePhe7lNKB Slide-mounted tissue sections were brought to room
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temperature and placed in a preincubation buffer (50 mM Tris-HCl, containing 
0.005% vol/vol, polyethylenimine, pH 7.4) at room temperature for 10 min.
Excess preincubation buffer was carefully removed with a gauze before adding the 
incubation buffer. To conserve radioligand, the incubation was accomplished by 
placing the slides on a horizontal surface in a humid chamber and covering the 
sections with about 500 /.i\ incubation solution per slide. Total binding was 
determined by incubation of slides for 60 min at room temperature in buffer 
containing 50 mM Tris-HCl (pH 7.4), 3 mM MnCl2, 0.02% (w/v) BSA, peptidase 
inhibitors (10 u^M phosphoramidon, 40 mg/L bacitracin, 2 mg/L chymostatin and 
4 mg/L leupeptin) and 0.2 nM 125I-[MePhe7]NKB according to Sadowski et al. 
(1993). To estimate non-specific binding, paired serial sections were incubated as 
described except that 1 fiM non-labelled [MePhe7]NKB, senktide, eledoisin or SP 
was also present in the incubation solution. Following incubation with 
radioligand, slides were transferred through four rinses (1 min each) in 50 mM 
Tris-HCl buffer (pH 7.4) at 4° C and rapidly dipped in cold deionized water. 
Excess water on the slides was carefully removed with a gauze, and they were 
rapidly dried at room temperature with an electric fan.
12SI-BHSP For labelling with l25I-BHSP (Substance P, [Na-l25-monoiodo- 
Bolton-Hunter]), the same protocol previously described was employed except that 
polyethylenimine was omitted from the preincubation and phosphoramidon was 
not included in the incubation buffer. Total binding was determined by using 0.1 
nM 125I-BHSP in the absence of unlabelled competitors while nonspecific binding
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was estimated using 0.1 nM 125I-BHSP in combination with 1 /*M unlabelled SP or 
related compounds (Mantyh et al., 1989).
Autoradiography
Film Autoradiogram To determine the overall localization of 125I- 
[MePhe7]NKB or 125I-BHSP binding sites in rat kidney, labelled sections were 
placed in close contact to Ultrofilm (Cambridge Ins., Nussloch, Germany) in light­
tight X-ray cassettes at 4° C. After six to fourteen days exposure, the films were 
developed in Kodak D-19 developer (1:1 dilution with water) at 20° C for 5 min, 
rinsed in water, then fixed in Kodak Rapid Fixer for 5 min. The labelled sections 
were then stained with hematoxylin and eosin. These sections and the adjacent 
stained sections were used to identify labeled structures in the film autoradiogram. 
To quantitatively estimate the density of radiolabelled tachykinin binding sites, the 
relative optical density (ROD) of selected regions on the film were measured 
using a microcomputer-based imaging device (MCID, Imaging Research Inc., 
Ontario, Canada). Briefly, areas of interest were identified on a video image of 
the autoradiogram using a mouse, and the computer determined the 
corresponding ROD. For each area of interest, six to eight readings from each 
section were obtained and means were calculated. A total of two to three 
sections from each animal were viewed. Final mean values were calculated from 
each animal. In all cases, specific binding of SP or [MePhe7]NKB to selected 
regions of the kidney was calculated by subtracting the ROD for the nonspecific 
binding autoradiogram from the ROD on the total binding autoradiogram (both
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corrected for film background). Nonspecific binding was defined as the binding 
which occurred in the presence of 1 /iM unlabelled peptide on a serially adjacent 
section.
Emulsion-coated Coverslip Autoradiogram When a higher degree of 
resolution was desirable, the same slide-mounted, labelled sections were processed 
by the emulsion-coated coverslip technique according to (Young and Kuhar,
1979). Briefly, acid washed coverslips (25 by 75 mm, Corning No. 0, Corning, 
New York) were dipped into Kodak NTB3 emulsion in the dark room under a 
safelight. The emulsion was diluted 1:1 with distilled water and liquified by 
heating to about 45 0 C in a water bath. After dipping, the coverslips were 
placed vertically in a dark box and allowed to dry overnight. The emulsion-coated 
coverslips were attached tightly to the slides of labelled tissue sections in the dark 
with super glue which was applied to one end of the slide and coverslip so as to 
serve as a hinge. The assembles were then placed in boxes and stored in the dark 
at 4°C. After an exposure period of four to six weeks, the coverslips were gently 
bent away from tissue at one end of the slide by inserting a O-tip. The emulsions 
were developed in Dektol for 5 min, washed in distilled water, fixed in Kodak 
Fixer for 5 min and rinsed in distilled water for 20 min at 4 °C. The tissue 
sections were then stained with hematoxylin and eosin. The Q-tips were removed 
after the tissue dried, and coverslips were permanently attached with Eukitt 
mounting medium. Slides were examined with a microscope under bright-field 
and dark-field illumination.
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Statistical Analysis
Functional Studies
Statistical differences among mean perfusion pressure responses to tachykinins 
were evaluated by one or two factor analysis of variance (ANOVA) and Dunnett’s 
test for the pairwise comparison of multiple means or by a paired t test, where 
appropriate. The results are expressed as means ± S.E. A P<0.05 was 
considered significant.
Receptor Autoradiography
Grain densities on film autoradiogram were expressed as relative optical 
density (ROD) x 1000 ± S.E. The different means of ROD between total and 
nonspecific binding or among different agonist treatments at selected regions were 
analyzed by three-way ANOVA, and differences for the pairwise comparison of 
multiple means were evaluated using Tukey’s test with P values less than 0.05 
being considered significant.
Drugs and Chemicals
Functional Studies
The peptides SP, NKA, kassinin, physaleamin, SP(l-7), [Sar9,M et(02)n ]SP and 
[MePhe7]NKB were purchased from Bachem Inc (Torrance, CA); GR-64349 
from Research Biochemical (Natick, MA); and All, PHE, NE, tyramine,
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thiorphan, indomethacin and capsaicin from Sigma (St. Louis, MO).
Phentolamine was obtained from Ciba Pharmaceutical Co (Summit, NJ). SP and 
related tachykinin agonists were dissolved in a solution of 0.9% NaCl and 0.01 N 
acetic acid (333 nmol peptide/100 fil) and stored in small aliquots at -70° C until 
used. GR64349 was dissolved in 0.01 N acetic acid. [MePhe7]NKB was dissolved 
in dimethylsulfoxide (DMSO) and diluted with distilled water to produce a stock 
solution containing 333 nmol/100 fi 1 (10% DMSO). All stock solutions of 
tachykinin were diluted at the time of use with saline containing 0.1% BSA. 
Control injections showed that DMSO alone (maximum 1% final concentration) 
had no affect on PP or the response to agonists under study. Thiorphan was 
initially dissolved in 0.25 N NaHC03 and diluted with perfusion buffer at the time 
of use (pH 7.4). Indomethacin and capsaicin were dissolved in 100% ethanol.
The maximum concentration of ethanol was 0.05% and had no significant effect 
on PP.
Receptor Autoradiography
125I-BHSP (2000 Ci/mmol) was purchased from Amersham (Arlington 
Heights, IL); 12SI-[MePhe7]NKB (2200 Ci/mmol) from Dupont NEN Research 
Products (Boston, MA); SP, [MePhe7]NKB, senktide and eledoisin from Bachem 
(Torrance, CA). Phosphoramidon, bacitracin, leupeptin, chymostatin, 
polyethylenimine, MnCl2, BSA and Tris-HCl (pH 7.4) were obtained from Sigma 
(St. Louis, MO). Dektol, Rapid fix, and NTB3 nuclear emulsion were purchased 
from Eastman Kodak, Rochester, N.Y. 125I-BHSP was prepared by the reaction
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of SP with N-succinimidyl 3-(4-hydroxy 5-[12SI] iodophenyl) propionate (Bolton and 
Hunter reagent). The lyophilized 125I-BHSP was reconstituted by addition of 0.01 
M acetic acid/fi-mercaptoethanol (50 fi Ci/500 fi 1) and stored as 40 fil aliquots in 
polypropylene tubes at -20 °C. [MePhe]NKB was labelled with 125I on His and 
supplied in a stock solution containing acetonitrile:water (35:65), 0.05M fi- 
mercaptoethanol, 0.13% TFA (trifluoroacetate salt), and 0.13% BSA by Dupont 
NEN Research. All peptidase inhibitors were dissolved in distilled water to 
produce stock solutions (0.2 jumol phosphoramidon/100 fi\, 800 fig bacitracin/100 
fil, 80 fig leupeptin/100 fi\, 40 fig chymostatin/100 fi\). These were stored in 
microtubes at -70° C until used.
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CHAPTER 4 
Results
Functional Studies
Pressor Responses to SP. NE and Tvramine in the Presence and Absence of PHE- 
induced Tone
Baseline PP was low in the absence of PHE, averaging about 74 mm Hg 
(Table 2), and bolus injections of 1 to 10 nmol SP had no effect on PP under this 
condition. A minor pressor response was generally noted with 33.3 nmol SP (Figs. 
3 and 4), however, this did not achieve statistical significance when compared to 
baseline PP. During perfusion with 1 n M PHE, the baseline PP was increased to 
about 136 mm Hg (Table 2), and SP elicited a dose-dependent pressor response. 
The largest dose of SP increased PP by 60 ± 5 mm Hg (n=5) under this 
condition (Figs. 3 and 4). A similar phenomenon of potentiation was observed 
with bolus injections of 100 pmol of NE and 10 /imol of tyramine (Table 3). The 
pressor response to NE was approximately 3-fold larger in the presence of PHE 
compared with the control response. In the case of tyramine, no PP response 
occurred in the absence of PHE; however, a substantial pressor response could be 
evoked by the same dose of drug in the presence of PHE.
Effect of Phentolamine on the Pressor Response to SP
In order to determine if the response to SP was mediated by NE, All was used
32
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TABLE 2.
Baseline perfusion pressure in the isolated perfused rat kidney in the 
absence and the presence of phenylephrine.
Treatment
Baseline Perfusion Pressure (mm Hel
-P H E + PHE
saline 74.2 ± 3.4 134.4 ± 5.9
1.0 nmol SP 73.8 ± 3.5 134.0 ± 7.1
3.3 nmol SP 73.4 ± 3.8 136.6 ± 8.1
10.0 nmol SP 74.2 ± 4.2 138.0 ± 7.6
33.3 nmol SP 75.2 ± 4.7 137.0 ± 6.3
The values indicated baseline PP before each bolus injection of SP and saline in 
the absence and the presence of 1 pM  phenylephrine (PHE). Data are expressed 
as mean ± S.E. (n=5). No significant difference ( P < 0.05 ) among each value 
in the absence or in the presence of PHE, respectively.
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presence (B) of 1 n M phenylephrine (PHE). Note that a brief injection artifact 
was produced by all bolus injections.
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TABLE 3.
Effect of phenylephrine to increase the pressor responses to NE and 
tyramine in the isolated perfused rat kidney
Perfusion Pressure (mm Hel
Treatment -PHE + PHE
baseline increase baseline increase
NE 60 ± 3 28.8 ± 7 126 ± 8* 96 ± 6.8*
Tyramine 57 ± 3 2.2 ± 0.5 121 ± 13* 42 ± 5*
Baseline PP and responses to bolus injections of 0.1 nmol NE and 10 fimo\ 
tyramine were measured before and after adding 1 fiM  phenylephrine (PHE) to 
the perfusion buffer. Data are expressed as mean ± S.E. (n=5). * Significantly 
different from corresponding value in absence of PHE.
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instead of PHE to increase vascular tone. Infusions of A ll increased baseline PP 
to 124 ± 7 mm Hg (n=5). Bolus injections of 33 nmol SP and 333 pmol NE 
evoked pressor responses in the presence of All, but only the response to NE was 
blocked by addition of 1 fiM  phentolamine to the buffer (Figs. 5 and 6). The 
pressor response to SP was slightly increased in the presence of phentolamine 
(Fig. 6).
Effects of Thiorphan. Captopril and Indomethacin on Pressor Response to SP 
As shown in Table 4, the pressor responses to SP were not potentiated by a 
neutral endopeptidase inhibitor (thiorphan) or an ACE inhibitor (captopril). In 
contrast, at the highest dose of SP tested, the responses to SP were smaller than 
they were in the absence of the peptidase inhibitors. Indomethacin potentiated 
the responses to 3.3 and 10 nmol of SP significantly compared to control. Each of 
the inhibitors had no significant effect on PP at the concentrations used (data not 
shown).
Comparison of the Dose-dependent Pressor Responses to SP. NKA, Kassinin. 
Phvsaleamin and SP( 1-71
In the presence of 1 fiM  PHE, SP produced a  dose dependent increase in PP. 
The amphibian tachykinins, physaleamin and kassinin had a similar pressor action 
to that of SP but caused a smaller response at the highest dose tested (Fig. 7). 
Although NKA could elicit a vasoconstrictor response, it was far less active than 
SP, physaleamin and kassinin (Fig. 7). The N-terminal fragment of SP, SP(l-7),
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TABLE 4.
Effect of thiorphan, captopril and indomethacin on the vasoconstrictor responses 
to SP in the isolated perfused rat kidney
Treatment Baseline 
(mm Hg)
SP dose (nmol')
1.0 J.O 10 33.3
Control 123 ± 9.4 3.3 ± 0.9 9.3 ± 1.5 16.7 ± 2.5 55.6 ± 6.7
Thiorphan (10 /zM) 112 ± 4.0 5.7 ± 0.7 11.7 ± 1.3 21.5 ± 1.9 48.8 ± 8.7*
Captopril (10 /zM) 125 ± 7.7 2.3 ± 0.8 7.2 ± 1.0 12.2 ± 1.5 36.5 ± 4.7*
Indomethacin (5 /zM) 124 ± 9.7 8.3 ± 2.0 18.7 ± 2.8* 31.5 ± 2.3* 59.8 ± 7.7
Phenylephrine (1 /zM) was used to increase baseline perfusion pressure in all groups. Treatment with 
inhibitors was started 30 min before injection of the first dose of SP. Values are means ± S.E. (n=6 for each 
group). ’Significantly different from control response at the same dose of SP (P < 0.05).
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Figure 7. Dose-response curves for increase in perfusion pressure 
produced by bolus injections of SP, physaleamin (Phy), kassanin (Kas), 
neurokinin A (NKA) and SP(l-7). TThe baseline perfusion pressure was 
increased by including 1 fiM PHE in the perfusion buffer. The points 
represent the mean and vertical bars the S.E. (n = 4-6 for each curve). 
•Significantly different from the response to SP at same dose.
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Effect of Selective Tachykinin Receptor Agonists on Perfusion Pressure 
Dose-response data for NK-1, NK-2 and NK-3 receptor agonists in the 
presence of PHE are shown in Figure 8. The selective NK-1 receptor agonist, 
[Sar9,M et(02)n]SP had no significant effect on PP at doses from 1 to 33.3 nmol.
By contrast, the selective NK-2 agonist, GR64349, and NK-3 receptor agonist, 
[MePhe7]NKB, both evoked dose-dependent pressor responses. The only 
significant difference between responses to GR64349 and [MePhe7]NKB occurred 
at the lowest dose tested and this was minor. Responses to NK-2 and NK-3 
agonists were significantly greater than those to SP at doses of 10 and 33.3 nmol.
Biphasic Effect of Capsaicin on Perfusion Pressure
As shown in Figures 9 and 10, infusions of capsaicin (500 nM final 
concentration) in the presence of 1 fxM PHE, produced an initial increase in PP 
followed by a more prolonged decrease. The maximum and minimum PPs 
achieved in response to capsaicin were significantly different from the baseline 
PP. Vehicle (0.01% ethanol) infusion produced a slight increase in PP (maximum 
of 6 ± 3 mm Hg) with a slower onset compared to capsaicin. The maximum PP 
achieved during vehicle infusion was not significantly different from baseline PP.
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Control Studies of the Rat Brain
125I-fMePhe7]NKB Autoradiographic studies revealed that in the coronal 
sections of the rat brain, specific 125I-[MePhe7]NKB binding sites are concentrated 
in cerebral neocortex, nucleus of the diagonal band and supraoptic nucleus. Much 
lower densities of specific binding are seen in other areas such as the caudate- 
putamen and paraventricular nucleus (Fig. lla,b,c and d). This distribution of 
NK-3 receptor binding sites in rat brain, as visualized with 12SI-[MePhe7]NKB, is 
similar to that previously reported using another NK-3 selective ligand, 
[3H]senktide (Dam et al, 1990; Stoessl and Hill, 1990; Quirion et al, 1991).
125I-BHSP The autoradiographic distribution of NK-1 receptors was visualized 
in rat brain using 125I-BHSP. Specific binding sites were most densely distributed 
in the olfactory tubercle and caudate-putamen (Fig. l i e  and f). This pattern is 
quite different from that observed with 125I-[MePhe7]NKB but in accord with a 
previous report on 125I-BHSP binding in the rat brain (Danks et al, 1986).
Localization of Specific (MePhe7]NKB Binding Sites in the Rat Kidnev
The localization of NK-3 receptors in rat kidney was subsequently evaluated 
by film and nuclear track emulsion autoradiography using 12SI-[MePhe7]NKB. 
Reverse image prints that were produced by using autoradiograms as negatives 
show 12SI-[MePhe7]NKB binding sites in rat kidney in Figures 12 and 13. A 
comparison of total binding and nonspecific binding reveals the presence of
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specific radioligand binding sites in the renal vein, inner strip of the outer 
medulla, pelvis and proximal ureter. The localization of a specific binding to the 
interlobar veins was also visible at the cortical/medullary junction (Fig. 13d,e and 
f). No specific binding was detected in the renal artery or the intrarenal arterial 
system by film autoradiography, although a high amount of nonspecific binding to 
renal artery was observed (Fig.12 and 13). Likewise, specific binding was not 
detected in the renal cortex (Fig. 12). Based on the measurement of ROD by 
computer-assisted image analysis (n=5), a high density of specific binding sites for 
12SI-[MePhe7]NKB was associated with the ureter and renal pelvis, a moderate 
density with the renal vein and a relatively low density with the inner strip of the 
outer medulla (Fig. 14). High resolution detection of 125I-[MePhe7]NKB binding 
sites was obtained in a few specimens by using the emulsion coated coverslip 
method. It was found that specific silver grains (black on the prints) were 
associated with the tunic media of the renal vein (Fig. 15b), the tunic muscularis 
of renal pelvis (Fig. 15d) and the tunic muscularis of ureter (Fig. 15f). Since no 
successful observations of the inner strip of the outer medulla were obtained by 
high resolution autoradiography, further definition of the location of specific 
binding sites in this region was not possible.
Competition studies using unlabelled senktide, eledoisin and SP, each at 1 
/iM, were performed to further characterize the binding sites identified by labeled 
[MePhe7]NKB (Table 5). For most regions, it was found that both senktide and 
eledoisin were comparable to [MePhe7]NKB in ability to compete with
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Figure 11. Autoradiographic visualization ([3H] Ultrofilm) of tachykinin binding 
sites in coronal sections of rat brain labeled by 0.2 nM I-[MePhe7]NKB (a,c ) or 
0.1 nM 12SI-BHSP (e). Plate b, d and f show nonspecific binding to adjacent 
sections in the presence of 1 fxM unlabelled ligands. B ar=2mm. CPu, Caudate- 
putamen; DB, nucleus of diagonal band; N, neocortex; OT, olfactory tubercule; 
PV, paraventricular nucleus; SO, supraoptic nucleus.
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Figure 12. Autoradiographic visualization ([3H] Ultrofilm) of 125I-[MePhe7]NKB binding sites in 
20 fxm frozen sections of rat kidney, (a) Total binding to section incubated with 0.2 nM 125I- 
[MePhe7]NKB; (b) Nonspecific binding to adjacent section incubated with 0.2 nM radioligand 
and 1 /jM  unlabeled ligand. Photos are reverse images, so grains appear white on a black 
background. Note the specific binding of 125I-[MePhe7]NKB to the inner strip of the outer 
medulla (OM), renal pelvis (P), renal vein (RV) and proximal ureter (U). High amount of 
nonspecific binding is seen on renal artery (RA). C, renal cortex; IM, inner medulla; 
Bar=5mm.
SC
50
Figure 13. Higher magnification of autoradiographic localization ([3H] Ultrofilm) 
of 125I-[MePhe7]NKB binding sites in rat kidney. Images in (b) and (e) represent 
total binding while those in (c) and (f) represent nonspecific binding, (a) and (d) 
are Lightfield photomicrographs of adjacent sections of (b) and (e), respectively, 
stained with hematoxylin and eosin. C, renal cortex; IA interlobar artery; IM, 
inner medulla; IV, interlobar vein; OM, outer medulla; P, renal pelvis; RA, renal 
artery; RV renal vein; Bar=50 fim.
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Figure 14. Evaluation of the regional density of l2sI-[MePhe8]NKB 
binding sites in rat kidney on film autoradiograms by computer- 
assisted image analysis. Values were expressed as mean relative 
optic density (ROD) x 1000 ± S.E (n=5). ‘significant difference 
between total and non-specific binding in the selected region. A P 
0.05 was considered significant. A, artery; M, medulla; V, vein.
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Figure 15. Light microscopic visualizations on emulsion-coated slides show 
125I-[MePhe7]NKB binding sites primarily over the tunica media (Med) of the 
renal vein (RV) in (b), the tunica muscularises (Mus) of renal pelvis (P) in (d) 
and ureter in (f). The microscope was focussed in the plane of the tissue 
(hematoxylin and eosin stain) for the photo in (a) while the focus was in the plane 
of the emulsion and silver grains in (b). Photographs in (c) and (e) show the 
hematoxylin and eosin staining pattern for sections corresponding to (d) and (f), 
respectively. Adv, tunic adventitia; IM, inner medulla; Muc, tunic mucosa;
Bar=50 //m in (a) and (c) and 1 mm in (e).
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TABLE 5.
Autoradiographic Distribution and Characterization of ^ I- [MePhe7] NKB
Binding Sites in Rat Kidney
Total binding ____________Nonspecific binding
Region MeNKB Senk Ele SP
Cortex 92 ± 13 87 ± 13 42 ± 5*t 79 ± 7 6 ± 2
Outer Stripe 94 ± 17 74 ± 9 34 ± 4* 69 ± 9 73 ± 7
Inner Stripe 244 ± 25 84 ± 11* 45 ± 8*t 99 ± 15* 124 ± 10*
Inner Medulla 85 ± 19 70 ± 12 38 ± 6*t 69 ± 8 71 ± 8
Pelvis 436 ± 19 67 ± 13* 36 ± 3** 82 ± 12’ 183 ± 27**
Renal Artery 248 ± 32 226 ± 25 227 ± 20 220 ± 10 228 ± 21
Renal Vein 409 ± 18 114 ± 1’ 85 ± 7 *t 143 ± 10* 221 ± 13**
Ureter 610 ± 31 110 ± 1* 106 ± 9* 227 ± 32** 379 ± 30**
Data are expressed as mean ROD X 1000 ± S.E.M (n = 5). * indicates 
significant difference from total binding and t indicates significant difference from 
nonspecific binding in the presence of the other agonists at selected region.
Total binding was determined by using 0.2 nM 125I-[MePhe7]NKB in the absence 
of unlabelled competitors while nonspecific binding was determined by using 0.2 
nM 12SI-[MePhe7]NKB in combination with 1 fiM unlabelled agonists. Ele, 
eledoisin; MeNKB, [MePhe7]NKB; Senk, senktide; SP, substance P.
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radioligand for binding sites. However, eledoisin was less effective than 
[MePhe?]NKB and senktide at the ureter. In addition, senktide competed for 
radioligand binding at more sites than the other agonists at the concentrations 
tested. SP was the least effective at blocking the binding of 125I-[MePhe7]NKB.
Localization of Specific SP Binding Sites in the Rat Kidney
Figures 16 and 17 illustrate the specific binding of 125I-BHSP to selected 
regions of the rat kidney with reverse images from film autoradiograms and ROD 
measurements, respectively. Specific binding of SP was detected on the renal 
artery, where it seemed to be located at the media/adventitia border or in the 
adventitia. Likewise, specific SP binding sites were present in the interlobar 
arteries (data not shown) and the renal pelvis. No specific binding sites for 125I- 
BHSP were seen in the renal vein and its branches, the renal cortex or the renal 
medulla (Fig. 17). Nonspecific binding of 125I-BHSP in the presence of 1 /rM SP 
was negligible.
Effect of Partially Occluding or Clamping Renal Vein on PP
As shown in Figure 18, when the isolated rat kidney was perfused at a constant 
flow rate in the presence of 1 /zM PHE as described previously, cannulating the 
renal vein with a small diameter polyethylene tubing or closing the vein with a 
hemostat produced a marked increase in PP.
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Figure 16. Autoradiographic visualization ([3H] Ultrofilm) of l2SI-BHSP binding sites in 20 /xm 
frozen sections of rat kidney, (b) Total binding to section incubated with 0.1 nM l25I-BHSP. (c) 
Nonspecific binding in adjacent section where 1 fiM  unlabelled SP was also added to the 
incubation medium, (a) Brightfield photomicrograph of adjacent hematoxylin and eosin stained 
section. Note that specific SP binding sites are associated with the renal pelvis (P) and renal 
arteries (RA) but not with the renal vein (RV). IM, inner medulla; Bar=lmm.
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Figure 17. Evaluation of regional density of 125l-BHSP binding sites in rat kidney 
on film autoradiogram by computer-assisted image analysis. Values were 
expressed as mean relative optic density (ROD) x 1000 ± S.E (n=5). Total 
bindings are determined with 0.1 nM labeled SP while nonspecific binding to 
adjacent sections was determined using 0.1 nM 125I-BHSP plus 1 SP or 
[Sar9,M et(02)n ]SP (sarSP). ‘significant difference between total and nonspecific 
binding in the selected region. A P < 0.05 was considered significant. A, artery; 
M, medulla; V, vein.
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Figure 18. Recorder tracings showing the marked increase in 
perfusion pressure produced by cannulation of the renal vein with 
small diameter polyethylene tubing or closing the renal vein with a 
hemostat in the isolated rat kidney in the presence of 1 /*M 
phenylephrine.
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Chapter 5 
Discussion
Functional Studies
Effect of Elevated Vessel Tone on Response to SP
SP had no effect on PP in the isolated perfused rat kidney when basal 
vascular tone was low but elicited a dose dependent vasoconstriction after 
baseline PP was increased by PHE or AIL A similar phenomenon was observed 
with single doses of NE and tyramine. These results indicate that, in the isolated 
perfused renal vascular bed of the rat, the magnitude of the response or the 
sensitivity of the renal blood vessels to vasoconstrictors depends upon the pre­
existing level of vascular tone. The same phenomenon has also been observed for 
a 2-adrenoceptor- and neuropeptide Y-mediated contractions in the isolated rat tail 
vascular bed with endothelin-1 used to generate tone (Maclean and Mcgrath, 
1990), the constrictor response of cat cerebral arteries to serotonin with 
mechanical elevation of transmural pressure (Harder, 1988) and All evoked 
contractions in rabbit femoral artery with NE used to adjust baseline tone (Prins 
et al, 1992). Since the vascular response to multiple pressor agents acting through 
different receptors is enhanced by elevation of vessel tone, it seems that this kind 
of potentiation results from a common alteration in intracellular mechanisms 
which regulate the contractile process.
It has been reported that elevation of transmural pressure causes a significant
58
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increase in inositol-triphosphate and diacylglycerol levels in isolated dog renal 
arteries (Harder et al, 1992). This suggests that the enhanced response to 
vasoconstrictors observed under this condition might be related to increased 
phospholipase C activity. Other investigators have also shown that the 
amplification of All-induced contractile responses by NE in rabbit femoral artery 
are attenuated markedly by nifedipine, a  calcium channel antagonist, implicating 
calcium channel activation in this phenomenon (Prins et al, 1992). In addition, 
Collins et a l (1992) have implicated protein kinase C activation in the contractile 
response that occurs to PHE in single vascular smooth muscle cells at constant 
intracellular free Ca+ + concentration. It has been demonstrated that all three 
tachykinin receptors have been linked to the phosphatidylinositol - calcium 
transduction system (Nakanishi, 1991). Likewise, both a j-adrenergic and All 
receptors are coupled to specific phospholipase C (Alexander et al, 1985; 
Steinberg et al, 1989; Takata et al, 1990). Therefore, one possible explanation 
for enhanced vasoconstrictor responses to SP and NE in the present study is that 
PHE and AH increase phospholipase C activity and the sensitivity of calcium- 
dependent and -independent steps in the contractile process.
Other mechanisms may be involved as well, such as membrane depolarization 
upon elevation of transmural pressure. Electrophysiological experiments have 
demonstrated that elevation of transmural pressure causes depolarization of the 
vascular smooth muscle and a significant increase in vessel sensitivity to NE 
(Lombard et al, 1990). Responses to tachykinins might also be potentiated under
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this condition.
The Role of NE in the Pressor Response to SP
It has been demonstrated that some of the effects of SP and other tachykinins 
appear to involve interactions with sympathetic neuroeffector control (Rand et al, 
1990). Immunocytochemical study has established that SP is present in cerebral 
perivascular axons and these axon terminals are in close proximity to those 
containing NE in the cerebral blood vessels (Matsuyama et al, 1986). Couture et 
al (1989) suggested tachykinins can accelerate heart rate by release of 
catecholamine through activation of NK-1 and/or NK-2 receptors, on 
noradrenergic fibers and adrenal chromaffin cells. Likewise, Tousignant et al 
(1987) have demonstrated that NKA facilitates the release of NE from 
sympathetic nerves in the rat vas deferens.
In rat kidney, anatomical studies have demonstrated that both the efferent 
sympathetic innervation and SP-containing nerve terminals reach many similar 
segments of the renal vasculature, including afferent and efferent arterioles, 
cortical capillaries, arcuate arteries and renal veins (Knight et al, 1987; Barajas et 
al, 1992). Stimulation of adrenergic nerves is known to cause a NE-mediated 
pressor response in the isolated perfused rat kidney (Schwartz and Malik, 1989). 
Therefore, it was possible that the pressor response to SP and the other 
tachykinins in the present study could have been an indirect effect mediated by 
NE released from sympathetic nerves. However, since phentolamine, an alpha- 
adrenergic receptor antagonist, blocked the pressor effect of NE but did not
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inhibit the effect of SP in this preparation, the pressor response to tachykinins in 
rat kidney is not mediated by NE.
Effects of Peptidase Inhibitors and Indomethacin on Response to SP
Degradation of peptides by proteases may influence their effect. Biochemical 
studies have indicated that both neutral endopeptidase 24.11 (NEP) and 
angiotensin convert enzyme (ACE) are capable of inactivating SP and other 
tachykinins in many organs and in various animal species (Stephenson and Kenny, 
1987; Turner, 1987; Frossard et al., 1989; Rouissi et aL, 1990). It has been 
reported that in the rat kidney NEP and ACE are mainly located in the proximal 
tubular brush border (Stephenson and Kenny, 1987; Turner, 1987). These 
enzymes are also present in the endothelium of some arteries and veins ( Turner, 
1987; llorens et aL, 1992). In the present study, the pressor effect of SP was not 
potentiated by treatment with thiorphan to inhibit NEP or captopril to inhibit 
ACE, suggesting that significant degradation of SP by these peptidases does not 
occur in this experimental condition. However, at the highest dose of SP tested, 
the pressor responses were reduced. The reason for this is not clear. One 
possibility is that thiorphan and captopril may have increased the quantity of 
bradykinin in the renal vasculature. Bradykinin can produce vasodilation not only 
as an endocrine hormone but also as an autocrine/paracrine mediator (Oza et al, 
1990; Carretero and Scicli, 1991; Campbell et aL, 1993). Moreover, it is known 
that bradykinin is a potent dilator in the rat renal circulation (Fulton et al, 1992) 
and can be produced in renal vessels from kallikrein-sensitive kininogens (Gardes
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et al, 1990). It is also known that bradykinin can be inactivated by both NEP and 
ACE, and endogenous bradykinin is thought to participate in the antihypertensive 
and renal effects of ACE and NEP inhibitors (Rouissi et al, 1990; Campbell et al, 
1993; Carretero and Scicli, 1991). Therefore, it is possible that intense 
vasoconstriction produced by the high dose of SP somehow stimulates the release 
of bradykinin from the renal vascular wall and that the peptidase inhibitors 
decrease its degradation. Consequently, a vasodilator effect from locally released 
bradykinin may partially counteract the vasoconstrictor response to SP.
Recently, Brelli et aL (1993) purified another enzyme from rat kidney that is 
also able to degrade SP. This enzyme, endopeptidase 24.16, is not sensitive to 
specific inhibitors of NEP 24,11 or ACE. It is not known if this enzyme has an 
impact on the response to SP in the isolated perfused kidney.
The pressor response to SP was not inhibited by the prostaglandin synthesis 
inhibitor, indomethacin, indicating that this response is not mediated by 
prostanoids. In contrast, the pressor response to SP was potentiated at 3 and 10 
nmol doses in the presence of indomethacin, indicating that SP may stimulate the 
release of some relaxant prostanoids in rat kidney. Kopp and Smith (1993a) 
demonstrated that renal sensory receptor activation by substance P, capsaicin and 
bradykinin is dependent on intact renal prostaglandin synthesis and suggest that 
prostaglandins play a permissive role in renal pelvic sensory receptor activation by 
many stimuli. This finding indicates that SP can stimulate production of renal 
prostaglandins. Devillier et al (1992) have demonstrated that SP causes
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relaxation of rat tracheal smooth muscle and at same time induces a 6 fold 
increase in tracheal PGE2 production. Preincubation with indomethacin abolished 
the relaxant effect of SP. It has also been reported that activation of tachykinin 
receptors is associated with the release of prostanoids, particularly PGEj, from 
macrophages (Hartung et aL, 1986).
Effect of Capsaicin on Perfusion Pressure
SP has been found coexisting with other neuropeptides such as CGRP within 
a subpopulation of primary sensory neurons which are widely distributed at both 
the somatic and visceral level including the rat kidney and renal vasculature.
These peptide containing neurons were found to be susceptible to the neurotoxic 
action of capsaicin (Wiessnfeld-Halllin et al, 1984; Manzini et al, 1991). In a 
variety of tissues and organs, acute exposure to capsaicin induces excitation of 
SP/CGRP-containing primary afferents that leads to calcium-dependent 
neuropeptide release and can be followed by prolonged insensitivity to various 
stimuli, including capsaicin itself, and neuronal degeneration. Manzini et al 
(1991) have demonstrated that superfusion of isolated rat mesenteric vascular bed 
with capsaicin produced a prompt and remarkable release of both SP-like and 
CGRP-like immunoreactivities from arteries and veins. It was also noted that in 
both tissues a second challenge with capsaicin resulted in no significant release of 
these peptides. In the present study, infusion of isolated rat kidney with capsaicin 
produced a biphasic effect on PP. It is possible that the pressor response might 
be through SP or tachykinins released from renal afferents, while vasodilation may
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be mediated by CGRP. Anatomical studies have shown that CGRP coexists with 
SP in primary sensory nerve terminals in rat kidney (Knight et al, 1991). There is 
also evidence that CGRP may have a vasodilator function in the renal vascular 
system (Geppetti et al, 1989).
Duckies (1986) has demonstrated that cat cerebral artery and guinea pig 
thoracic aorta are locally regulated by sensory neuropeptides such as SP.
Capsaicin transiently vasoconstricted these vessels before causing a vasodilation, 
but the vasoconstrictor effect in these vessels appeared to be a direct action not 
mediated by sensory neuropeptides. However, direct effects of capsaicin have not 
been observed in all kinds of vascular beds of different species. For example, in 
guinea pig isolated perfused heart, 1 n M capsaicin caused a substantial release of 
SP and coronary vasodilation (Hoover, 1987). A second challenge with the same 
concentration of capsaicin did not release SP or affect perfusion pressure. These 
findings suggest that the effect of capsaicin on the guinea pig coronary vasculature 
is entirely mediated by sensory neuropeptides. Maggi and Meli (1988) proposed 
that desensitization of the acute responses to capsaicin is a useful functional 
marker to distinguish specific effects consequent to activation of sensory nerves 
from nonspecific effects of this substance. Therefore, further work will be needed 
for a conclusive determination regarding the ability of endogenous tachykinins to 
affect the renal vasculature.
Effects of Tachykinin Analogs on Perfusion Pressure
Amino-terminal Fragment of SP: SPd-7) Structure-activity studies have
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demonstrated that C-terminal fragments of tachykinins which are six amino acids 
in length or longer retain the biological actions of tachykinins, such as the 
contraction of smooth muscle. Amino-terminal fragments of tachykinins, on the 
other hand, lack activity at tachykinin receptors (Maggio, 1988). However, the N- 
terminus of tachykinins is involved in receptor-independent effects observed at 
high tachykinin concentrations. Jacques et al. (1989) have found that two 
positively charged amino acids (i.e., Arg and Lys) at the N-terminal of SP are 
essential for the triggering of prostaglandin and histamine release by this 
tachykinin. These responses appear to be mediated by the direct activation of a 
pertussis toxin sensitive G protein (Mousli et al., 1990). The observation that 
SP(l-7) was essentially inactive in the present study suggests that the pressor 
response to tachykinins in isolated perfused rat kidney is C-terminal dependent 
and a tachykinin receptor-mediated event rather than a consequence of direct G- 
protein stimulation. The ability of other natural tachykinins (i.e., physaleamin, 
kassinin and NKA) to elicit a pressor response in rat kidney also supports the 
conclusion that tachykinin receptors are involved, since these peptides lack the 
structural features required for producing receptor-independent responses.
Selective Tachykinin Receptor Agonists Natural tachykinins have a very 
limited ability to discriminate among the three classes of tachykinin receptors. In 
the absence of selective tachykinin agonists and antagonists, the classification of 
tachykinin receptors in mammalian tissues has been based chiefly upon the 
relative order of potency of natural peptides and their analogues in various
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
66
bioassays or binding experiments (Lee et al, 1986; Regoli et aL, 1987). Recently, 
several tachykinin analogues with a high degree of selectivity as agonists have 
been reported (Regoli et al, 1988; Regoli et al, 1991b). [MePhe7]NKB is a 
potent and highly selective agonist for the NK-3 receptor (Regoli et aL, 1988). In 
the present study, [MePhe7]NKB was shown to exert a dose-depentent 
vasoconstrictor responses that was significantly greater than that to SP. This 
suggests that NK-3 receptors contribute to the pressor action of tachykinins in rat 
kidney. Other investigators have provided evidence that NK-3 receptors are also 
present in the rat portal and mesenteric veins and likewise mediate 
vasoconstriction at these sites (Mastrangelo et al, 1986; Orleans-Juste et al, 1991).
In addition, the experiments described here also indicate that a population of 
NK-2 receptors is present in the renal vasculature of rat. This is based on the fact 
that the natural NK-2 agonist, NKA contracted renal blood vessels. Furthermore, 
the selective NK-2 agonist, GR64349 [(Lys3,Gly8-R-Y-lactam-leu9)NKA(3-10)] 
which has been shown to possess marked selectivity for NK-2 receptors over NK-1 
and NK-3 receptors (Hagan et al, 1991), caused a marked pressor effect that was 
essentially equal to that of the NK-3 agonist, [MePhe7]NKB.
In spite of the fact that NKA has a higher affinity than SP for NK-2 and NK-3 
receptors (Regoli et al, 1988), NKA was less potent than SP in evoking a pressor 
response in the rat kidney. This discrepancy may be due to degradation of NKA 
by peptidases in the kidney. Hagan et al (1991) have demonstrated that the
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potency of NKA in contracting guinea pig trachea was increased by over 100 fold 
in the presence of peptidase inhibitors. In contrast, our previous studies have 
demonstrated that the potency of SP in the isolated perfused rat kidney was not 
affected by peptidase inhibitors (Chen and Hoover, 1992).
During the course of this study, we also tried to determine the effect of two 
other selective NK-2 agonists (i.e., NIe10-NKA(4-10) and Ala8-NKA(4-10)) and the 
endogenous NK-3 receptor ligand, NKB. These experiments were not successful 
because of the limited water solubility of these compounds. This factor made it 
necessary to use DMSO as a vehicle, and DMSO affected PP substantially at the 
dilutions that would be required to achieve tachykinin concentrations in the 
effective range.
Using M et(02) as the C-terminal residue and replacing Gly9 with Sar 
(sarcosine), a potent and selective NK-1 receptor agonist was obtained that was 
three fold more active than SP on the NK-1 and inactive on the NK-2 and NK-3 
receptor systems (Regoli et al, 1988). In the present study, [Sar9,M et(02)n ]SP 
was inactive, suggesting that the pressor effect of tachykinins is not mediated by 
NK-1 receptors in rat kidney.
Although it has been proven that SP and [Sar9,M et(02)u ]SP are potent 
hypotensive agents in the rat in vivo (Couture et al., 1989), these peptides caused 
no vasodilation in rat renal vasculature in the present study, even though the 
endothelium was intact, as demonstrated by the ability of acetylcholine to elicit a 
vasodilator response in this preparation (data not shown). The present finding
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therefore suggests that NK-1 receptor activation is not involved in any detectable 
vasoactive response of the rat isolated kidney. Thus, this particular vascular bed 
may not contribute to the overall hypotensive effect of SP administered 
intravenously in the rat.
Studies of in vitro Receptor Autoradiography
NK-3 Receptors in Rat Brain
125I-[MePhe7]NKB has been reported as a high affinity and selective ligand for 
the human and rat NK-3 receptors (Sadowski et al, 1993). In the present study 
we used 125I-[MePhe7]NKB to determine the presence and localization of NK-3 
receptors in rat brain and kidney. In our control study using coronal sections of 
rat brain, the distribution of NK-3 binding sites visualized with 12SI-[MePhe7]NKB 
was very similar to that previously reported using another NK-3 selective ligand, 
[3H]senktide (Dam et al, 1990; Stoessl and Hill, 1990; Quirion et al, 1991). 
Furthermore, 125I-[MePhe7]NKB binding to rat brain was completely blocked in 
the presence of excess unlabeled senktide. These data give further support to the 
conclusion that 125I-[MePhe7]NKB is a highly selective ligand for the NK-3 
receptor.
NK-3 Receptors on the Renal Vein
Film autoradiography with 12SI-[MePhe7]NKB demonstrated that NK-3 
receptors are found on the rat renal veins and their large branches. Experiments 
with higher resolution emulsion autoradiography revealed the localization of these
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NK-3 receptors on the vascular tunica media. Unexpectedly, no specific binding 
sites for [MePhe7]NKB were detectable in the renal artery system. Now the 
question has to be raised as to whether the [MePhe7]NKB binding sites shown in 
renal veins in autoradiography corresponded to NK-3 receptors identified in our 
functional studies. Generally, it is considered that in the physiological condition, 
the venous system makes little contribution to vascular resistance, especially in the 
renal vascular bed (Ulfendahl and Wolgast, 1992). However, the fact that 
clamping the renal vein significantly increased PP in the isolated rat kidney 
suggests that intense constriction of the renal vein following bolus injection of the 
tachykinins would be expected to increase PP when the isolated kidney is perfused 
at a constant flow rate. Indeed, SP and NKB are constrictors of isolated veins 
such as the rat portal vein and rabbit jugular vein (Mastrangelo et al, 1986;
Nantel et a l, 1990). Furthermore, neurokinins act on the mesenteric bed of the 
rat to increase the PP of the venous vasculature via activation of NK-3 receptors 
while NK-3 agonists are inactive on the arterial mesenteric vasculature 
(Orleans-Juste et a l, 1991). These results are in agreement with those we 
obtained in isolated rat kidney.
The study of venous function has always been second to that of arterial 
function. This is in part due to the assumption that the responses of arteries are 
more important than those of veins. It must also be because of the 
methodological problems involved in the study of the venous circulation and the 
responses of the veins have to be interpreted indirectly from other measures in
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vivo. However, recently, with the double simultaneously perfused mesenteric 
arterial and venous preparation which allows the responses of the arteries and 
veins of a single perfused vascular bed to be compared, Warner (1990) has 
demonstrated that the vasoactive agents such as NE, All and arginine vasopressin 
show pronounced arterial-venous selectivity and the venous portion of the 
vasculature is significantly involved in the responses of the intact circulation.
Other investigators (Grega and Adamski, 1987) also indicate that large vein 
constriction is proportionately greater than the large artery constriction to NE and 
venous resistance may also contribute in an important manner to increase in total 
vascular resistance. Large vein constriction not only decreases vascular volume, 
promoting increases in venous return, but may provide 15-20% of the total 
resistance to flow during local infusions of NE, serotonin, or dopamine in the 
cutaneous vasculature.
Grega and Adamski (1987) intimate that patterns of neurogenic constriction 
may be as diverse as those produced by vasoconstrictor agents, and these 
differences may reflect the interplay between function and design to subserve 
specific physiological activities. Large vessels participate in vasoconstrictor 
responses triggered by stimuli that impose a severe stress on the circulation. 
Constriction of large arteries and large veins is, for example, a characteristic 
feature of circulatory shock states. In contrast, small vessels participate primarily 
in normal vascular adjustments required to maintain blood pressure at the set 
point. Certainly the physiological significance of the occurrence of NK-3
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receptors on the rat renal veins remains to be elucidated. However, the local 
release of sensory neuropeptides such as tachykinin in renal venous bed might 
have functions more than changes of the renal capacitance and venous return by 
the control of venous tone. For example, they may be mediate the defense 
response through neurogenic inflammation or have a trophic role for tissue 
protection and repair (Maggi and Meli, 1988).
The doses of [MePhe7]NKB used in our perfusion study were relatively higher 
than that used in isolated mesenteric veins (Orleans-Juste et aL, 1991).
Differences in receptor density on the vessels may contribute to this difference in 
sensitivity. Additionally, the unique characteristics of the renal vascular bed may 
be another factor. Since NK-3 receptors were on the renal venous side and the 
tachykinins were administered from renal arterial side in functional studies, these 
peptides had to pass through partial filtration in glomeruli and partial exchange in 
second capillaries in renal medulla and possible enzyme inactivation along the 
way before reaching to receptor sites.
NK-3 Receptors on the Renal Pelvis and Ureter
In addition to renal veins, specific [MePhe7]NKB binding sites were also found 
on the renal pelvis and ureter. These results are consistent with some anatomic 
and functional studies. It has been demonstrated that the walls of the renal pelvis 
and ureter are rich in unmyelinated nerve fibers (Marfurt and Echtenkamp, 1991) 
and SP-immunoreactive nerves were found to innervate these sites (Knight et aL, 
1987; Ferguson and Bell, 1985). NKB-like immunoreactivity has been found in
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homogenate of rat kidney (Tateishi et al, 1990), however, there have been no 
studies on the localization of NKB immunoreactive fibers in the rat kidney. Urine 
produced in the kidney is propelled toward the urinary bladder by ureteral 
peristalsis, which is a primarily myogenic phenomenon initiated by pacemaker 
cells in the proximal part of renal pelvis (Constantinous, 1974). Circular muscle 
strips of the guinea pig renal pelvis exhibit a spontaneous phasic contractile 
activity, which is augmented by NKA and SP (Maggi et al., 1992). Electrical field 
stimulation produces a positive inotropic effect that is unaffected by atropine and 
guanethidine but abolished by in vitro capsaicin desensitization (Maggi et al,
1992). Contractile effects of NKA and SP were also observed in the ureter 
(Hua et al, 1987; Amann et al, 1988). These data suggest that the release of 
tachykinins from primary afferents may produce local motor responses in the 
renal pelvis and ureter. This action may be a defensive mechanism which could 
facilitate removal of irritants present in the urine and protect the kidney during 
obstruction and ureteral antiperistalsis (Maggi et a l, 1992).
NK-3 Receptors on the Outer Medulla of Kidney
Film autoradiography has shown that 12SI-[MePhe7]NKB binds specifically in a 
lower density to the inner stripe of the outer medulla in rat kidney. However, the 
resolution of this method does not permit a discrimination among the various 
potential cellular sites for NK-3 receptors in these areas. It has been recognized 
that the renal medulla plays a fundamental role in maintaining body fluid and 
electrolyte homeostasis through the medullary microcirculation and through
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urinary concentrating mechanisms (Wilhelm, 1981).
Anatomically, the renal medulla is divided into an outer medulla subdivided 
into an outer stripe and inner stripe, and an inner medulla. The renal medulla is 
composed of the loops of Henle and the collecting ducts and vessels. The inner 
stripe comprises descending thin limbs, ascending thick limbs and collecting ducts. 
The blood supply of the medulla in intact kidney is entirely postglomerular. The 
juxtamedullary efferent arterioles divide in the outer stripe to form the descending 
vasa recta which then descend through the medulla in cone-shaped bundle. At 
intervals a descending vasa rectum leaves the bundle to supply an adjacent 
capillary plexus. The physiological role of NK-3 receptors in the inner stripe of 
the outer medulla remains to be clarified. Several cell types could serve as the 
targets of tachykinins within this architecture.
It has be reported that intrarenal infusion of SP produces an increase in renal 
blood flow, urine volume and sodium excretion in dog (Pemow, 1983; Defelice 
and Brousseau, 1988). These effects result presumably from the endothelium 
dependent vasodilator action of SP on afferent glomerular arterioles of the kidney 
(Cairns et a l, 1991). Other investigators demonstrated that in anesthetized rats, 
infusion of SP at 50 pg/min into the abdominal aorta above the renal arteries 
produces diuretic and natriuretic effects which are considered to be responsible 
for the reduction of salt and water reabsorption by proximal convoluted tubule 
(Arendshorst et a l, 1976). Whether SP or other tachykinins have any effect such 
as modulation of sodium and water transport through tachykinin receptors in the
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thick ascending limbs of the loop of Henle or other tubular component in the 
renal medulla is unknown.
In the renal medulla, interstitial cells, like the rungs of the ladder are 
transversely interposed between the longitudinally running tubules and vessels and 
are thought to adjust the distance between tubules and vessels (Wilhelm, 1981). 
They specifically produce prostaglandins (PGs) (Wilhelm, 1981; Kopp and Smith, 
1993a), and stimulation of renal PG production by SP has been suggested in the 
present study and other investigations (Kopp and Smith, 1993a). Thus, 
SP/tachykinins might act on these cells to produce PGs, which in turn can have 
widespread influences on medullary structures. Prostaglandins can antagonize the 
effects of vasopressin on collecting ducts (Wilson, 1992), which may contribute to 
the diuretic actions of SP. PGs also inhibit sodium reabsorption by collecting 
tubules provoking natriuresis and diuresis (lino and Imai, 1978; Stokes and 
Kokko, 1977).
Another possible site of tachykinin binding is the pericyte, a modified smooth 
muscle cell that replaces smooth muscle around the descending vasa recta 
(Wilhelm, 1981). Tachykinin acting here could influence medullary blood flow 
patterns, perhaps reducing the efficiency of countercurrent mechanisms and 
leading to natriuresis. Furthermore, if NK-3 receptors are on these cells, they 
may be involved in neurogenic inflammation of the kidney. Tachykinins have 
been found to enhance vascular permeability through a direct action on capillary- 
venular permeability, and NK-3 receptors have been proposed to mediate this
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response (Couture and Kerouac, 1987).
Both senktide and eledoisin were able to compete with [MePhe7]NKB for 
binding sites in the rat kidney, and this was anticipated based on their known high
affinities for the NK-3 receptor. However, it was not anticipated that senktide
would be more effective than [MePhe7]NKB in competing with radiolabelled 
[MePhe7]NKB at selected sites. This suggests that specific binding sites in 
different regions of the kidney may differ regarding the relative affinities of these 
NK-3 agonists and hints at the possibility of receptor subtypes. As expected, SP 
was less effective than all other agonists in competing with radiolabelled 
[MePhe7]NKB for binding sites in rat kidney. This is consistent with the fact that 
SP binds to NK-3 receptors with a much lower affinity than at NK-1 and NK-2 
receptors. Nevertheless, the autoradiographic results do document binding of SP 
to NK-3 receptors and support the suggestion that pressor responses to SP are 
due at least in part to effects at NK-3 receptors.
SP Binding Sites in Rat Kidney
125I-BHSP is one of the ligands which has been used in many NK-1 receptor 
binding studies (Quirion et al., 1991). In our control sections of rat brain, a high 
density of specific 12SI-BHSP binding sites was observed in the caudate-putamen 
and olfactory tubercule which is in agreement with previous reports (Mantyh et 
al, 1989; Danks et al, 1986).
Specific BH-SP binding sites in section of rat kidney were primarily confined 
to the renal artery and its large branches, where the grains appeared to be
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localized to the media/adventitial border or the adventitia. Like 125I- 
[MePhe7]NKB, specific binding of radiolabelled SP was also identified in the renal 
pelvis. Based on the known K<, values for SP at the three types of tachykinin 
receptor, relatively selective labelling of the NK-1 receptor was anticipated at the 
concentration of radiolabelled SP used in this study. Furthermore, binding of 
radiolabelled SP was completely eliminated in the presence of unlabeled SP and 
[Sar9,M et(02)11]SP, a NK-1 selective agonist. Accordingly, the sites identified with 
radiolabelled SP are most likely to be NK-1 receptors.
Stephenson et a l (1987) have reported that 125I-BHSP binding to dog kidney 
was localized over glomeruli and endothelium of intrarenal arteries and 
endothelium and adventitia of the renal artery. In this species, SP produces a 
vasodilator effect on dog kidney through stimulation of NK-1 receptors on 
vascular endothelium and release of EDRF. Although specific binding of BH-SP 
was also associated with the rat renal artery in the present study, these sites 
appeared to be associated with adventitia instead of intima.
There is strong evidence that capsaicin sensitive afferent neurons participate 
in afferent sensitization and the reflex regulation of renal functions in addition to 
the possible local effect on the tone of vessels, pelvis and ureter. Renal 
mechanoreceptors are mechanosensitive fibers that monitor hydrostatic changes 
within the kidney while renal chemoreceptors respond to alterations in the 
composition of the interstitial or pelvic environment (Kopp, 1993). Evidence that 
SP fibers may be involved in the transmission of afferent input from the kidney to
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the central nervous system is provided by investigations that combined retrograde 
fluorescent dye labeling and immunolocalization methods. In studying the rat and 
guinea pig, Su et a l (1986) found a dense network of SP and CGRP fibers 
associated with the smooth muscle and epithelium of the renal pelvis, and in the 
interlobar branches of the renal artery and in the hilar connective tissue.
Ferguson et a l (1986) also reported abundant SP-immunoreactive nerve fibers in 
the wall of the proximal ureter and renal pelvis and around the larger renal blood 
vessels. These findings emphasize the possible importance of SP and CGRP- 
positive fibers in renal afferent transmission. It has been shown that renal pelvic 
administration of SP increased ipsilateral afferent renal nerve activity and 
contralateral urine flow rate and urinary sodium excretion (Kopp and Smith, 
1991). Furthermore, the NK-1 receptor antagonist CP-96,345 produced a 
competitive blockade of the increase in afferent renal nerve activity (Kopp and 
Smith, 1993b). These data suggested that the presence of functional SP receptors 
in the renal pelvic area, activation of which would result in a similar inhibitory 
contralateral renorenal reflex responses as increased ureter pressure. The results 
of our in vitro autoradiography using 125I-BHSP showed the presence of NK-1 
receptors in the walls of renal artery and renal pelvis of rat and may represent an 
anatomical correlate of the above referenced functional observations. Thus, the 
NK-1 receptors present in the rat renal artery and pelvis might have a function 
different from that of NK-3 receptors localized in renal vein and pelvis. 
Neuropeptides such as SP present in primary sensory nerve terminals may have
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dual role through different tachykinin receptors in the maintenance of 
homeostasis. Stimuli such as increased ureteral pressure or renal ischemia may 
activate one kind of tachykinin receptors (e.g., NK-1) on afferents in renal blood 
vessel or renal pelvis and ureter, to transmit the perceived information to the 
central nervous system and initiates both voluntary and autonomic reflexes. 
Additionally, activation of another tachykinin receptor (e.g., NK-3) could lead to 
local tissue responses at the site of stimulation to promote resistance of the tissue 
against further damage and aid the repair of injury.
Summary
1. Tachykinins can cause a vasoconstrictor effect in the rat renal vascular bed 
which has some pre-existing tone produced by phenylephrine or angiotensin 
II.
2. The vasoconstrictor effect of SP is not blocked by phentolamine, indicating 
that norepinephrine does not mediate this response.
3. The pressor response to SP is not enhanced by thiorphan or captopril, 
indicating that neutral endopeptidase and ACE are not involved in SP 
degradation under the experimental conditions.
4. The pressor response to SP is not mediated by vasoconstrictor prostanoids, 
but SP may release some relaxant prostanoid in rat kidney.
5. The N-terminal fragment SP (1-7) had no effect on PP, indicating that the 
pressor response to SP is C-terminal dependent and tachykinin receptor
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mediated.
6. The selective NK-1 receptor agonist, [Sar9,M et(02)11]SP, was inactive and the 
selective NK-2 and NK-3 receptor agonists, [MePhe7]NKB and GR64349, 
resulted in much larger pressor responses than that of SP. These 
observations suggest that the vasoconstrictor effect of tachykinins in the 
isolated rat kidney is mediated by NK-2 and NK-3 receptors.
7. Capsaicin produced a biphasic change of renal vascular tone, indicating that 
endogenous sensory neuropeptide might be able to influence the renal 
vasculature.
8. By in vitro receptor autoradiography, specific NK-3 ligand binding sites were 
localized to the vascular tunica media of the renal vein, tunic muscularis of 
the renal pelvis and ureter and inner strip of the outer medulla, while NK-1 
receptors were localized to the renal artery and pelvis.
9. Partially occluding or clamping the renal vein increased perfusion pressure in 
the isolated rat kidney.
Conclusion
Tachykinins have vasoconstrictor effects mediated by tachykinin receptors in 
the isolated perfused rat kidney. Experiments with selective tachykinin agonists 
established that these responses could occur through stimulation of NK-2 and/or 
NK-3 receptors. Activation of NK-3 receptors on smooth muscle of the renal vein 
can increase perfusion pressure in the isolated kidney perfused at a constant rate.
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NK-2 receptors mediating pressor responses could be on smooth muscle of the 
renal resistance vessels and/or the renal vein. However, the localization of NK-2 
receptors in the renal vasculature still needs to be determined by using selective 
radioligands.
Implications for Further Research 
The present studies with synthetic tachykinins and their agonists have 
demonstrated the pharmacological effects of tachykinins in the isolated perfused 
rat kidney and provided some anatomical localization of tachykinin receptors 
within the kidney. However, the physiological significance of these findings is 
currently unknown and would be an interesting and important topic for future 
study. Results from preliminary work with capsaicin reported here could indicate 
that endogenous sensory neuropeptides are able to produce local effects in the 
kidney. However, the possibility that capsaicin may have a direct local constrictor 
effect unrelated to sensory neuropeptides needs to be eliminated.
In vitro film autoradiography of frozen kidney sections revealed a low density 
of NK-3 receptors in the inner strip of the outer medulla, but it lacked adequate 
resolution to localize receptors to specific cells. Further investigation by using 
improved high resolution light and electron microscopic autoradiography (Zhou et 
al, 1992) will be needed to determine the cellular localization of these receptors.
Finally, studies are necessary to clarify the pathophysiological role of 
neuropeptides released from capsaicin sensitive nerve terminals in the renal
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pathological animal models or some human disease such as certain types of 
hypertension to investigate possible tachykinin involvement.
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